The treatment of chronic hepatitis C virus (HCV) infection has the potential to change
significantly over the next few years as therapeutic regimens are rapidly evolving. However …

METHODS We conducted a systematic study which represents one of the most
comprehensive effort to quantify global HCV epidemiology, using the best available …

Hepatitis C virus (HCV) exhibits high genetic diversity, characterized by regional variations
in genotype prevalence. This poses a challenge to the improved development of vaccines …

The hepatitis C virus (HCV) is an extremely diverse virus, subtypes of which are distributed
variably around the world. Viral genotypes may be divided into epidemic subtypes; those …

Detailed, country‐specific epidemiological data are needed to characterize the burden of
chronic hepatitis C virus (HCV) infection around the world. With new treatment options …

It is well established that hepatitis C develops into cirrhosis of the liver and hepatocellular
carcinoma (HCC) both of which are fatal diseases. The World Health Organization estimates …

Egypt is the most affected nation by hepatitis C virus (HCV) and needs a comprehensive
characterization of HCV epidemiology to inform the scale-up of treatment and prevention …

Abstract Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country …

Chronic hepatitis C, attributed to infection with hepatitis C virus (HCV), is a global health
problem. The overall prevalence of viral hepatitis worldwide is estimated to be 3–5% with …

Background Hepatitis C virus (HCV) has different genotypes throughout the world. Since the
determination of which antiviral treatment to be applied is related to HCV genotypes …